Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease

References

• Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173(6):639–643.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352(17):1749–1759.
   PubMed Web of Science ®Google Scholar
• De Serres G, Lampron N, La Forge J, Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 2009; 46(2):129–133.
   PubMed Web of Science ®Google Scholar
• Camargo CA, Jr., Ginde AA, Clark S, Cartwright CP, Falsey AR, Niewoehner DE. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 2008; 3(4):355–359.
   PubMed Web of Science ®Google Scholar
• Ramaswamy M, Groskreutz DJ, Look DC. Recognizing the importance of respiratory syncytial virus in chronic obstructive pulmonary disease. COPD 2009; 6(1):64–75.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf. Accessed July 1, 2011.
   Google Scholar
• Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008; 12(7):703–708.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370(9589):765–773.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11):e442.
   PubMed Web of Science ®Google Scholar
• Make B, Belfer MH. Primary care perspective on chronic obstructive pulmonary disease management. Postgrad Med 2011; 123(2):145–152.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117(2 suppl):5S–9S.
   PubMed Web of Science ®Google Scholar
• Kherad O, Kaiser L, Bridevaux PO, Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest 2010; 138(4):896–904.
   PubMed Web of Science ®Google Scholar
• Langley GF, Anderson LJ. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011; 30(6):510–517.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98(5):708–715.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Cunningham CK, Barker WH, Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172(2):389–394.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Formica MA, Walsh EE. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol 2002; 40(3):817–820.
   PubMed Web of Science ®Google Scholar
• Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of Adl: A standardized measure of biological and psychosocial function. JAMA 1963; 185:914_919.
   PubMed Web of Science ®Google Scholar
• The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little, Brown & Co; 1994.
   Google Scholar
• Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189(2):233–238.
   PubMed Web of Science ®Google Scholar
• Hall CB, Douglas RG, Jr., Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 1976; 89(1):11–15.
   PubMed Web of Science ®Google Scholar
• Hall CB, Geiman JM, Douglas RG, Jr., Meagher MP. Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978; 62(5):728–732.
   PubMed Web of Science ®Google Scholar
• Hall CB, Kopelman AE, Douglas RG, Jr, Geiman JM, Meagher MP. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300(8):393–396.
   PubMed Web of Science ®Google Scholar
• Hall CB. Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended. Clin Infect Dis. 2000; 31(2):590–596.
   PubMed Web of Science ®Google Scholar
• Mazzulli T, Peret TC, McGeer A, Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis. 1999; 180(5):1686–1689.
   PubMed Web of Science ®Google Scholar
• Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(2):347–360.
   PubMed Web of Science ®Google Scholar
• Baillard C, Boussarsar M, Fosse JP, Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003; 29(4):584–589.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16(1):63–70.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514–1519.
   PubMed Web of Science ®Google Scholar
• Baumgarth N, Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 1996; 70(7):4411–4418.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Herre JM, Lawson ML, Cole SK, Burke BL, Hooton JW. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 2004; 22(5-6):681–688.
   PubMed Web of Science ®Google Scholar
• Reyes E, Prieto A, de la Hera A, Treatment with AM3 restores defective T-cell function in COPD patients. Chest 2006; 129(3):527–535.
   PubMed Web of Science ®Google Scholar
• Todisco T, Vecchiarelli A, Dottorini M, Interferon-gamma (r-IFN-gamma) induced activation of alveolar macrophages (AM) from anergic patients with chronic obstructive pulmonary disease (COPD). J Biol Regul Homeost Agents. 1992; 6(3):87–92.
   PubMed Web of Science ®Google Scholar
• Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982; 142(1):85–89.
   PubMed Web of Science ®Google Scholar
• Kaba NK, Francis CW, Hall WJ, Falsey AR, Smith BH. Protein S declines during winter respiratory infections. J Thromb Haemost 2003; 1(4):729–734.
   PubMed Web of Science ®Google Scholar
• Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998; 351(9114):1467–1471.
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable COPD. Am J Respir Crit Care Med 2001; 164:1618–1632
   PubMed Web of Science ®Google Scholar
• Borg I, Rohde G, Loseke S, Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J 2003; 21(6):944–951.
   PubMed Web of Science ®Google Scholar
• Walsh EE. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 2011; 32(4):423–432.
   PubMed Web of Science ®Google Scholar